Spearman’s correlation coefficients between urinary L-FABP levels with clinical characteristic of patients.

<p>ACR, albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate.</p><p>Spearman’s correlation coefficients between urinary L-FABP levels with clinical characteristic of patients.</p

Baseline patient characteristics.

<p>Data are mean (SD), median (IQR), or number of patients (%). ACR, albumin-to-creatinine ratio; ACE/ARB, angiotensin-converting enzyme/angiotensin-receptor blocker; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate.</p><p>Baseline patient characteristics.</p

Independent predictors of urinary L-FABP^* in multivariate linear regression models.

<p>^*Log-transformed variables.</p><p>ACR, albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; ACE/ARB, angiotensin-converting enzyme/angiotensin-receptor blocker.</p><p>Independent predictors of urinary L-FABP<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0126990#t003fn001" target="_blank">^*</a> in multivariate linear regression models.</p

Urinary L-FABP levels and anemia.

<p>Patients with anemia had significantly higher urinary L-FABP levels than patients without anemia (5.6 μg/gCr [2.3–20.2] vs. 3.3 μg/gCr [0.2–7.4], P = 0.002).</p

Urinary L-FABP levels and albuminuria.

<p>Patients with albuminuria had significantly higher urinary L-FABP levels than patients without albuminuria (7.9 μg/gCr [2.0–21.2] vs. 2.8 μg/gCr [0.3–6.1], P < 0.001).</p

Additional file 1 of Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats

Additional file 1: Figure S1. Western blot analysis of eye CD31 (a) and α-Tubulin on the same membrane (b) in each group. Western blot analysis of eye eNOS (c), and α-Tubulin on the same membrane (d) in each group. The red lines represent the edge of each cut membrane